Congress Program

Preliminary Program Subject to change

Monday, 15 October

08:00-16:30

Registration

08:30-08:35

Congress Opening and Welcome from Congress Chair
Thomas Wilckens,
Germany & Israel

08:35-10:30

Session I: Rare Diseases an Avenue to #Precision Medicine
Session Chair: Catherine Brownstein, Harvard, USA

Genomics, Precision Medicine, and Rare Diseases at Boston Children’s Hospital
Catherine Brownstein, Harvard, USA

Improving Rare Disease Diagnosis with Metabolomics
John Ryals, Metabolon Inc, USA

Precise but Agile Biomarker Approaches in Pharmaceutical R&D. How to Avoid Ending up with a Stamp Collection?
Peter Groenen, Idorsia, Switzerland

Deciphering Autoimmunity & Inflammation with Multi-omics & AI
Thomas Wilckens, InnVentis Ltd., Israel

10:30-11:00

Coffee & Networking Break

11:00-12:30

Session II: Moving Forward in Chronic Diseases
Session Chair: Elena Bonfiglioni, Microsoft, Belgium

Towards a Systems Approach for Chronic Diseases, with More Agility
Michael Rebhan, Novartis, Switzerland

The PRECISESADS Project: Towards the Reclassification of the Systemic Autoimmune Diseases
Marta Alarcón Riquelme, Genyo, Spain

  • Diagnosis of autoimmune diseases is delayed and leads to bad therapeutic responses because it uses clinical criteria instead of molecular pathways.
  • We aim at molecularly reclassify systemic autoimmune diseases
  • The integration of high level transcriptome/methylome data leads to a new disease classification where the clinical diagnoses do not match the molecular groups.

Precision Medicine @Microsoft Focus on Immunity Mapping
Elena Bonfiglioni, Microsoft, Belgium

Alzheimer’s Disease: From Differential Diagnosis to Precision Medicine
Maria Teresa Ferretti, University of Zurich, Switzerland

12:30-13:30

Lunch & Networking Break

13:30-15:00

Session III: Artificial Intelligence, the Enabler of Precision Medicine
Session Chair: Thomas Wilckens, InnVentis Ltd., Israel

AI in Healthcare: Implementation Strategies and Enterprise Valuation
Justus Wolff, Syte, UK

Next Generation Data Science in Precision Medicine: A Roadmap to Create Insight and Avoid Data Deluge
Alexander Manta, InnVentis Ltd, Israel

Predicting Personal Immune Scenarios
Enkelejda Miho, FHNW Switzerland, Switzerland

Deep Learning in Life Sciences: Successes, Methods, and Applications
Günter Klambauer, Johannes Kepler University Linz, Austria

 15:00-15:30

Coffee & Networking Break

 15:30-17:30

Session IV: Artificial Intelligence in #Precision Medicine: Applications & Challenges
Session Chair: TBC

Evidence Synthesis -- A New Frontier for Machine Learning/AI (Back to the Future)
Athula Herath, Novartis, UK

Using AI and Real-World Evidence to Take the “Trial and Error” out of Prescribing
Dekel Taliaz, Taliaz Ltd., Israel

Real World Medicine and Real World Patients: Critical Understanding for Translational and Precision Medicine
Michael Liebmann, IQ Analytics, USA

Systems Medicine - or - What I Learned About Arnold Schwarzenegger While Studying Breast Cancer Survival
Jan Baumbach, Technical University of Munich, Germany

 17:30

End of Day One

Tuesday, 16 October

 08:00-16:30

Registration 

 08:30-10:30

Session V: Omics as Drivers of Innovation
Session Chair: Mark Punyanitya, PhenoMx Inc., USA

The Ultimate Quantified Self: A Digital Physical Examination for Precision Medicine
Mark Punyanitya, PhenoMx Inc., USA

Combining Radiological, Clinical and Genomic Data: The Future of Data Driven Medicine in Oncology
Thierry Colin, SOPHiA GENETICS, France

Liquid Biopsies’ Potential Beyond Cancer 
Simon Lucas, Merck KGaA, Germany

Precision Metabolomics™
Nicolas Schauer, Metabolon Inc., USA

 10:30-11:00

Coffee & Networking Break

 11:00-12:30

Session VI: Precision Medicine for Infectious Diseases  
Session Chair: TBC


Precise Instead of Broad-Spectrum: The Coming Wave of Biological Antibiotics
Alexander Belcredi, PhagoMed Biopharma GmbH, Austria

 
Precision Medicine in Infectious Diseases
Achim Plum, Curetis N.V.

 12:30-13:30

Lunch & Networking Break

 13:30-15:00

Session VII: Next Generation Clinical Trials
Session Chair: Armin Furtwängler, Boehringer Ingelheim, Germany

Next Generation Clinical Research
Armin Furtwängler,
Boehringer Ingelheim, Germany

Clinical Trial Innovation: How Learnings from Oncology can Lead the Way
Christian Meisel, Roche, Germany

Will IoHT Provide the Key to Precision Medicine?
Marie Mc Carthy, ICON plc, Ireland

15:00-15:30

Coffee & Networking Break

15:30-17:30

Session VIII: Financing Disruption
Session Chair: Horst Domdey, Bio-M, Germany


Agile, Collaborative & Open: New Ways to Shape Health Innovation
Thomas Brenzikofer,
 DayOne, Switzerland
  • What is health innovation: from doing things better to doing things different
  • Why collaboration is the key success factor in health innovation
  • The building blocks of an innovation hub

 
The Valley Prospective 
Ajit Singh, Artiman Ventures, USA 

17:30

End of Congress